Companies: 10,795·Total market cap: $144.5T
CDT Equity Inc.

CDT Equity Inc.

CDTNASDAQHealthcare● Active
$0.78
+$0.04(+5.30%)
Market Cap$3765221
P/E Ratio
52W High$610
52W Low$0.6859

CDT Equity Inc. (CDT) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

cdt · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for CDT Equity Inc. (CDT) measures how much investors pay for each dollar of the company's trailing earnings. CDT's current PE ratio of 0.00x is calculated by dividing its stock price of $0.78 by its TTM earnings per share of $426.55.

0.00x
P/E Ratio (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
EPS (TTM)
$426.55
TTM · diluted EPS
PEG Ratio
0.00
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · CDT Equity Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2021 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
CDT Equity Inc.
CDT Equity Inc.You
CDT
$4M0.00x$426.55
Concord Medical Services Holdings Limited
Concord Medical Services Holdings Limited
CCM
$1MN/A-$637.37
Envoy Medical, Inc.
Envoy Medical, Inc.
COCH
$14MN/A-$1.21
Enveric Biosciences, Inc.
Enveric Biosciences, Inc.
ENVB
$1MN/A-$36.24
Hepion Pharmaceuticals, Inc.
Hepion Pharmaceuticals, Inc.
HEPA
$1MN/A-$0.88
Lixte Biotechnology Holdings, Inc.
Lixte Biotechnology Holdings, Inc.
LIXT
$82MN/A-$0.12
NewGenIvf Group Limited
NewGenIvf Group Limited
NIVF
$0M0.49x$16.80

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 5 of 5 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-1177.90
2024-12-31
FY2024
$-61591.80
2023-12-31
FY2023
$-2396.46
2022-12-31
FY2022
$-20134.93
2021-12-31
FY2021
$-63470.30

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for CDT Equity Inc. (CDT) measures how much investors pay for each dollar of the company's trailing earnings. CDT's current PE ratio of 0.00x is calculated by dividing its stock price of $0.78 by its TTM earnings per share of $426.55.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.78 ÷ $426.55 = 0.00x
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

CDT pe ratio · 6 questions

CDT's current PE ratio is 0.00x as of 2026-06-09, based on a stock price of $0.78 and TTM EPS of $426.55. Data sourced from Financial Modeling Prep via CDT's SEC 10-K and 10-Q filings.

CDT PE ratioWhat is CDT PE ratioCurrent PE ratio of CDTCDT PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · CDT Equity Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09